Tablets in two strengths, 130 milligram (mg) and 65 mg (The tablets may be cut into smaller pieces for lower doses.) Hyperthyroidism, iodine induced autoimmunity (Grave's and Hashimoto type), toxic nodular goitre and iodine-induced hypothyroidism have been reported as side effects of iodine therapy. Owing to the sensitivity of the neonate and foetus thyroid to large doses of iodine, repeated administration of stable iodine should be avoided for neonates and pregnant and lactating women. Neonates will not require further doses. Pregnant and breastfeeding women should take a maximum of two doses.

Dairy Free, Egg Free, Gluten Free, Milk Free, No artificial sweeteners, flavours, colours or preservatives., Non GMO, Peanut Free, Shellfish Free, Soy Free, Tree Nut Free, Vegan, Wheat Free Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:Q & A: Information about Public Health Issues Related to Polonium-210 Contamination in the United Kingdom

Remarks on the need for potassium iodide made by Commission Chairman Nils Diaz of the Nuclear Regulatory Commission on 11/10/2001…” use of potassium iodide pills would have significantly reduced the incidence of thyroid cancer [during Chernobyl]”. Iodine is actively transported into breast milk, however those breast feeding should continue to do so (see section 5.2). Lactating women should avoid repeat doses (see section 4.2). An overactive thyroid gland, thyroiditis, and an enlarged thyroid gland with or without development or myxoedema have also been reported.Young adults. This group is less sensitive to the potential damage from radioactive iodine. But it’s still important for them to take the medication. In cases of exposure to radioiodine from nuclear accidents, dosing of potassium iodate should be based on emergency plans and predetermined operational intervention levels. Risk benefit of administration of stable radioiodine should be considered for the different age groups at risk. Pregnant and lactating women, neonates, infants and children should be treated first. A single dose of potassium iodate gives adequate protection for one day. Prolonged exposure may require repeat dosing, however repeat dosing in the neonate, and in pregnant and lactating women should be avoided (see section 4.2). Iodine prophylaxis is used against inhaled radioiodine and should not be the main prophylaxis for ingested contamination.